Please assess the completion status of the following clinical trial:

Trial Title: Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* must have completed 24 weeks of dosing of the CL0600-020 study~Exclusion Criteria:~* none

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- teduglutide (Type: EXPERIMENTAL): 0.05 mg/kg/day

Based on this trial design, predict the completion outcome and termination type (if applicable).